Adding Memantine to Rivastigmine Therapy in Patients with Mild-to-moderate Alzheimer's Disease: Results of a 12-Week, Open-Label Pilot Study.
Primary care companion to the Journal of clinical psychiatry（2006）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要